The U.S. government has been discussing with drugmakers how to raise overseas drug prices as President Donald Trump seeks to ...

Lilly has been chasing—and gaining on—its chief metabolic medicine rival Novo Nordisk and its counterpart GLP-1s Ozempic and ...

Following a barrage of letters from President Donald Trump urging 17 large pharmaceutical companies to implement Most Favored ...

Presidential office said on Aug. 7 that the United States had pledged most-favored-nation (MFN) treatment on future ...

German drugmaker Merck KGaA on Thursday joined peers in saying it was considering distribution models that serve U.S.

It’s a bad time to try to predict future pharmaceutical prices.

Late last week, President Donald Trump sent letters to 17 pharmaceutical companies pressing them to deliver on his May ...

The government is in talks with pharmaceutical companies to raise the prices of certain medications outside the U.S.

Aside from the MFN order, President Trump is also in the process of negotiating tariffs with countries all over the world. It ...

The Trump Administration is pursuing decidedly anti-growth policies. The results will be a weaker economy that violates his ...

BACKGROUND Since taking office on January 20, 2025, the Trump Administration has undertaken an aggressive trade policy that ...